Robert Forgan Halenbeck

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods of use for MGD-CSF in disease treatment
- Patent number 8,575,312
- Issue date Nov 5, 2013
- Five Prime Therapeutics, Inc.
- Dirk Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for MGD-CSF in disease treatment
- Patent number 8,178,109
- Issue date May 15, 2012
- Five Prime Therapeutics, Inc.
- Dirk Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulation, solubilization, purification, and refolding of tissue...
- Patent number 7,226,757
- Issue date Jun 5, 2007
- G.D. Searle LLC
- Glenn J. Dorin
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Protein associated with cell stress response
- Patent number 7,186,530
- Issue date Mar 6, 2007
- Chiron Corporation
- Dong Wei
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Formulation, solubilization, purification, and refolding of tissue...
- Patent number 7,022,672
- Issue date Apr 4, 2006
- Chiron Corporation
- Glenn J. Dorin
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Recombinant PR-3 and assays employing the same
- Patent number 6,599,706
- Issue date Jul 29, 2003
- Chiron Corporation
- Robert F. Halenbeck
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant PR-3 and compositions thereof
- Patent number 6,586,222
- Issue date Jul 1, 2003
- Chiron Corporation
- Robert F. Halenbeck
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant human CSF-1 dimer and compositions thereof
- Patent number 6,322,779
- Issue date Nov 27, 2001
- Chiron Corporation
- Robert Halenbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of solubilizing, purifying, and refolding protein
- Patent number 6,323,326
- Issue date Nov 27, 2001
- Chiron Corporation
- Glenn J. Dorin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of solubilizing, purifying, and refolding protein
- Patent number 6,319,896
- Issue date Nov 20, 2001
- Chiron Corporation
- Glenn J. Dorin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding N∇2 CSF-1 (short form) and carboxy truncated f...
- Patent number 6,204,020
- Issue date Mar 20, 2001
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments...
- Patent number 6,156,300
- Issue date Dec 5, 2000
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding NV2 (long form) and carboxy truncated fragments thereof
- Patent number 6,146,851
- Issue date Nov 14, 2000
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N.gradient.2-CSF-1(long form) and carboxy truncated fragments thereof
- Patent number 6,117,422
- Issue date Sep 12, 2000
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N.gradient.2 CSF-1 (short form) and carboxy truncated fragments the...
- Patent number 6,103,224
- Issue date Aug 15, 2000
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Secreted mac-2-binding glycoprotein
- Patent number 6,069,127
- Issue date May 30, 2000
- Chiron Corporation
- Kirston E. Koths
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification of M-CSF agonists and antagonists
- Patent number 6,025,146
- Issue date Feb 15, 2000
- Chiron Corporation
- Jayvardhan Pandit
- G01 - MEASURING TESTING
Information Patent Grant
Compositions for the inhibition of TNF hormone formation and uses t...
- Patent number 5,998,378
- Issue date Dec 7, 1999
- Chiron Corporation
- Michael Kriegler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding secreted Mac-2 binding glycoprotein
- Patent number 5,965,382
- Issue date Oct 12, 1999
- Chiron Corporation
- Kirston E. Koths
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallization of M-CSF.alpha.
- Patent number 5,866,114
- Issue date Feb 2, 1999
- Chiron Corporation
- Jayvardhan Pandit
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant human CSF-1 dimer and compositions thereof
- Patent number 5,861,150
- Issue date Jan 19, 1999
- Chiron Corporation
- Robert Halenbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Assay method for screening for inhibitors of proTNF conversion
- Patent number 5,843,693
- Issue date Dec 1, 1998
- Chiron Corporation
- Robert F. Halenbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Native type II GAP, methods for purifying various GAPs and uses of...
- Patent number 5,830,684
- Issue date Nov 3, 1998
- Chiron Corporation
- Robert Halenbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Secreted Mac-2-binding glycoprotein
- Patent number 5,736,340
- Issue date Apr 7, 1998
- Chiron Corporation
- Kirston E. Koths
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding N- and C- terminally truncated colony stimulating fact...
- Patent number 5,681,719
- Issue date Oct 28, 1997
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N- 3 deletion mutants of the long form of CSF-1
- Patent number 5,672,343
- Issue date Sep 30, 1997
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimers forms of CSF-1 and pharmaceutical compositions thereof
- Patent number 5,651,963
- Issue date Jul 29, 1997
- Chiron Corporation
- Robert Halenbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for purifying secreted Mac-2-binding glycoprotein
- Patent number 5,644,035
- Issue date Jul 1, 1997
- Chiron Corporation
- Kirston E. Koths
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-.gradient.3 deletion mutants of the short form of CSF-1
- Patent number 5,643,563
- Issue date Jul 1, 1997
- Chiron Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding various forms of colony stimulating factor-1
- Patent number 5,573,930
- Issue date Nov 12, 1996
- Cetus Oncology Corporation
- Martha B. Ladner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENT
- Publication number 20140170145
- Publication date Jun 19, 2014
- Five Prime Therapeutics, Inc.
- Dirk Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods of Use for MGD-CSF in Disease Treatment
- Publication number 20120258071
- Publication date Oct 11, 2012
- Five Prime Therapeutics Inc.
- Dirk Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENT
- Publication number 20110003384
- Publication date Jan 6, 2011
- Five Prime Therapeutics, Inc.
- Dirk BEHRENS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Leader Sequences For Directing Secretion of Polypeptides and Method...
- Publication number 20080286834
- Publication date Nov 20, 2008
- Robert Forgan Halenbeck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Formulation, Solubilization, Purification, and Refolding of Tissue...
- Publication number 20080281084
- Publication date Nov 13, 2008
- Novartis Vaccines and Diagnostics, Inc.
- Glenn J. Dorin
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
Compositions and Methods of Use for Mgd-Csf in Disease Treatment
- Publication number 20070264277
- Publication date Nov 15, 2007
- Dirk Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel protein associated with cell stress response
- Publication number 20070128710
- Publication date Jun 7, 2007
- Chiron Corporation, a Delaware corporation
- Dong Wei
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Formulation, solubilization, purification, and refolding of tissue...
- Publication number 20060128947
- Publication date Jun 15, 2006
- Chiron Corporation
- Glenn J. Dorin
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

Robert Forgan Halenbeck

Person

Patents Grantslast 30 patents

Compositions and methods of use for MGD-CSF in disease treatment

Compositions and methods of use for MGD-CSF in disease treatment

Formulation, solubilization, purification, and refolding of tissue...

Protein associated with cell stress response

Formulation, solubilization, purification, and refolding of tissue...

Recombinant PR-3 and assays employing the same

Recombinant PR-3 and compositions thereof

Recombinant human CSF-1 dimer and compositions thereof

Method of solubilizing, purifying, and refolding protein

Method of solubilizing, purifying, and refolding protein

DNA encoding N&#x02207;2 CSF-1 (short form) and carboxy truncated f...

Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments...

DNA encoding NV2 (long form) and carboxy truncated fragments thereof

N.gradient.2-CSF-1(long form) and carboxy truncated fragments thereof

N.gradient.2 CSF-1 (short form) and carboxy truncated fragments the...

Secreted mac-2-binding glycoprotein

Identification of M-CSF agonists and antagonists

Compositions for the inhibition of TNF hormone formation and uses t...

Nucleic acid encoding secreted Mac-2 binding glycoprotein

Crystallization of M-CSF.alpha.

Recombinant human CSF-1 dimer and compositions thereof

Assay method for screening for inhibitors of proTNF conversion

Native type II GAP, methods for purifying various GAPs and uses of...

Secreted Mac-2-binding glycoprotein

DNA encoding N- and C- terminally truncated colony stimulating fact...

N- 3 deletion mutants of the long form of CSF-1

Heterodimers forms of CSF-1 and pharmaceutical compositions thereof

Method for purifying secreted Mac-2-binding glycoprotein

N-.gradient.3 deletion mutants of the short form of CSF-1

DNA encoding various forms of colony stimulating factor-1

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENT

Compositions and Methods of Use for MGD-CSF in Disease Treatment

COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENT

Leader Sequences For Directing Secretion of Polypeptides and Method...

Formulation, Solubilization, Purification, and Refolding of Tissue...

Compositions and Methods of Use for Mgd-Csf in Disease Treatment

Novel protein associated with cell stress response

Formulation, solubilization, purification, and refolding of tissue...

DNA encoding N∇2 CSF-1 (short form) and carboxy truncated f...